Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Videos

Supporting UCL's Entrepreneurs

We work with UCL's students and staff to help them realise their ambitions. We provide training courses, organise networking events, identify sources of funding, find customers for their products and help them protect and exploit their intellectual property



Working with Business

We work closely with many business partners in joint research collaborations and product development. We also provide business services including training courses, continuing professional development and consultancy



Commercialising our Assets

With our wholly owned company UCL Business we are committed to protecting and commercialising assets derived from research activities and we welcome opportunities to work closely with partners to co-develop commercial products



Corporate Partnerships